Resources

DecisionDx-Melanoma Resources: Educational & Clinical Support

Hear from experts and patients alike and learn more about DecisionDx-Melanoma’s precise, personalized and proven results.

Expert opinions on the treatment and management of cutaneous melanoma

  • Play interview with Muhammad A Salamat, MD on uncovering the limitations of traditional approaches to risk assessment

    Uncovering the limitations of traditional approaches to risk assessment

  • Play interview with Shannon Trotter, DO, on how DecisionDx-Melanoma can accurately predict individual risk of recurrence and/or metastasis

    How DecisionDx-Melanoma can accurately predict individual risk of recurrence and/or metastasis

  • Play interview with Scott Dinehart, MD on improving patient selection for the SLNB surgical procedure

    Improving patient selection for the SLNB surgical procedure

  • Play interview with Eric Whiteman, MD, FACS, on how Castle us changing the management of dermatologic cancers

    How Castle is changing the management of dermatologic cancers 

  • Play interview with John Vetto, MD, on the role of molecular prognostic tests in managing dermatologic cancers

    The role of molecular prognostic tests in managing dermatologic cancers

Explore case studies

View real-world examples of how gene expression profile (GEP) testing with DecisionDx-Melanoma can help guide risk-aligned care for patients diagnosed with cutaneous melanoma

View case studies

Hear a patient's journey with DecisionDx-Melanoma

As a stage III melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.

Order the DecisionDx-Melanoma test

Order Test

Explore on-demand webinars

  • Incorporating prognostic gene expression profiling in the management of skin cancer

    Faculty: Shannon Trotter, DO Oakview Dermatology

    James Sligh, MD, PhD Bay Pines VA Medical Center

     

    CME/CE: CME (1.0 AMA PRA Category 1 Credit(s)) 

    Access Now

  • Use of a genomic-based prognostic tool to inform clinical decisions for patients with cutaneous melanoma

    Faculty: Shannon Trotter, DO Oakview Dermatology

    Joseph Michael Guenther, MD
    St. Elizabeth Physicians

     

    CME/CE: CME (Credit Expiration Date: July 31, 2021)

    Access Now

  • Incorporating DecisionDx-Melanoma into clinical practice: molecular information for personalized management decisions

    Faculty: Darrell S. Rigel, MD, FAAD Clinical Professor of Dermatology New York University Grossman Medical School
    St. Elizabeth Physicians

     

    CME/CE: N/A

    Access Now

  • Castle Biosciences - revolutionizing gene expression profiling in clinical management of dermatologic cancers

    Faculty: Aarron Farberg, MD, FAAD Baylor University Medical Center, Dallas TX

     

    CME/CE: N/A

    Access Now

  • 31-GEP: sentinel lymph node biopsy guidance

    Faculty: John Vetto, MD, FACS

     

    CME/CE: N/A

    Access Now

  • DecisionDx-Melanoma: predicting individualized risk of recurrence

    Faculty: James Sligh, MD, PhD

     

    CME/CE: N/A

    Access Now

Learn about related tests

View All Tests